Silk Road Medical, Inc (NASDAQ:SILK) Q1 2024 Earnings Call Transcript April 30, 2024 Silk Road Medical, Inc beats earnings expectations. Reported EPS is $-0.36, expectations were $-0.4. SILK isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good day, and thank […]
Silk Road Medical (SILK) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Silk Road Medical (SILK) announces its latest launch of ENROUTE Transcarotid Neuroprotection System PLUS, which is likely to aid in TCAR procedures.